제목2
Biopharmaceuticals: 단일클론항체 (mAb), Fc 융합 단백질, 백신, FSH 및 EPO와 같은 당단백질 호르몬.
Cells: 포유류 세포주, 박테리아 세포 구성 요소
Biological samples: 환자의 혈장, 체액, 조직 및 기타
Infected samples and cell lines: COVID-19 환자 샘플 및 세포주
|
Regulatory requirements |
Ludger Glycan Analysis Service |
|
Quantitative Monosaccharide Analysis |
√ |
|
Quantitative Sialic Acid Analysis |
√ |
|
Glycan Profiling Analysis |
√ |
|
Glycan Antennary Profiling Analysis |
√ |
|
Linkage |
√ |
|
Details Glycan Characterization |
√ |
|
Glycosylation Site Analysis |
√ |
|
GCQAs |
Ludger Glycan Analysis Service |
|
Degree of Mannosylation |
√ |
|
Degree of Galactosylation |
√ |
|
Degree of Fucosylation |
√ |
|
Degree of Sialyation / Charge distribution |
√ |
|
Human vs. Non-Human Sialic Acids |
√ |
|
Detection and Relative Quantitation of N-glycans containing the Galα1-3 Gal Epitope |
√ |
|
Compliance documentation for GMP |
√ |